MARKET

BLFS

BLFS

Biolife Solutions Inc
NASDAQ

Real-time Quotes | Nasdaq Last Sale

13.95
+0.14
+1.01%
Opening 12:17 07/01 EDT
OPEN
13.67
PREV CLOSE
13.81
HIGH
14.21
LOW
13.67
VOLUME
78.97K
TURNOVER
755.57K
52 WEEK HIGH
60.67
52 WEEK LOW
10.40
MARKET CAP
591.62M
P/E (TTM)
-43.8266
1D
5D
1M
3M
1Y
5Y
Billionaire Israel Englander Is Betting Big on These 5 Stocks
Investor Place · 06/24 16:22
BioLife Solutions Deploys SciSafe's Ultra Low Controlled Temperature Trailers To Extend Domestic Cold Chain Services
BioLife Solutions, Inc. (NASDAQ:BLFS), a leading supplier of class-defining bioproduction tools and services for the cell and gene therapies ("CGT") and broader biopharma markets, today announced that its
Benzinga · 06/09 12:13
Investing in BioLife Solutions (NASDAQ:BLFS) five years ago would have delivered you a 496% gain
The last three months have been tough on BioLife Solutions, Inc. ( NASDAQ:BLFS ) shareholders, who have seen the share...
Simply Wall St. · 06/02 16:34
B. Riley Lowers BioLife Solutions' Price Target to $34 from $48, Keeps Buy Rating
MT Newswires · 05/17 09:17
--KeyBanc Lowers BioLife Solutions Price Target to $30 From $60, Overweight Rating Kept
MT Newswires · 05/10 10:51
BioLife Solutions, Inc. (BLFS) Reports Q1 Loss, Lags Revenue Estimates
BioLife Solutions, Inc. (BLFS) delivered earnings and revenue surprises of 29.17% and 4.36%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Zacks · 05/09 21:45
BRIEF-BioLife Solutions Q1 GAAP Loss Per Share $0.17
reuters.com · 05/09 21:25
BioLife Solutions Q1 EPS $(0.17) Down From $(0.03) YoY, Sales $36.22M Up From $16.85M YoY
BioLife Solutions (NASDAQ:BLFS) reported quarterly losses of $(0.17) per share. This is a 466.67 percent decrease over losses of $(0.03) per share from the same period last year. The company reported $36.22 million in
Benzinga · 05/09 20:27
More
No Data
Learn about the latest financial forecast of BLFS. Analyze the recent business situations of Biolife Solutions Inc through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 9 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

22.22%Strong Buy
66.67%Buy
11.11%Hold
0.00%Under-perform
0.00%Sell
Analyst Price Target
The average BLFS stock price target is 37.13 with a high estimate of 68.00 and a low estimate of 28.00.
High68.00
Average37.13
Low28.00
Current 14.33
EPS
Actual
Estimate
-0.25-0.13-0.010.12
Q2 2021
    0
Q3 2021
Q4 2021
Q1 2022
Q2 2022
Institutional Holdings
Institutions: 194
Institutional Holdings: 37.40M
% Owned: 88.19%
Shares Outstanding: 42.41M
TypeInstitutionsShares
Increased
72
2.12M
New
27
584.46K
Decreased
41
1.65M
Sold Out
35
868.64K
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Medical Equipment, Supplies & Distribution
+1.52%
Healthcare Equipment & Supplies
+1.28%
Key Executives
Chairman/Chief Executive Officer/Director
Michael Rice
President/Chief Operating Officer
Roderick de Greef
Chief Financial Officer/IR Contact Officer
Troy Wichterman
Executive Vice President/Chief Scientific Officer
Aby Mathew
Chief Marketing Officer
Todd Berard
Vice President/Director of Human Resources
Sarah Aebersold
Other
Karen Foster
Other
Marcus Schulz
Independent Director
Amy DuRoss
Independent Director
Rachel Ellingson
Independent Director
Joydeep Goswami
Independent Director
Joseph Schick
No Data
No Data
About BLFS
BioLife Solutions, Inc. develops, manufactures, and markets bioproduction tools and services to the cell and gene therapy (CGT) industry and the broader biopharma market. Its products are used in basic and applied research and commercial manufacturing of biologic-based therapies. It has a portfolio of tools and services that focus on biopreservation, cell processing, frozen biologic storage products and services, cold-chain transportation, and thawing of biologic materials. Its tools portfolio includes its CryoStor and HypoThermosol biopreservation media for shipping and storage, the ThawSTAR family of automated, water-free thawing products, evo cold chain management system, high capacity cryogenic storage freezers, Stirling Ultracold mechanical freezers, SciSafe biologic storage services, and Sexton Biotechnologies cell processing tools. Customers use its products to maintain the health and function of biologic material during sourcing, manufacturing, storage, and distribution.

Webull offers kinds of BioLife Solutions Inc stock information, including NASDAQ:BLFS real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, BLFS stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading BLFS stock methods without spending real money on the virtual paper trading platform.